UNSPSC 51143009: Dalfampridine or fampridine

This classification denotes a cation channel blocker with the molecular formula C5H6N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BH3B64OKL9, chemically known as 4-pyridinamine, monohydrochloride but generally known as fampridine, which bears US NIH Compound Identifier 1727. European Medicines Agency schedules Fampridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07505MIG.

The term FAMPRIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). World Health Organization schedules fampridine in its Anatomical Therapeutic Chemical (ATC) Classification. Dalfampridine or fampridine bears US NLM identifiers UMLS ID C0000477 and NCI Concept Code C76777. SMILES: C1=CN=CC=C1N.

UNSPSC 51143009 Dalfampridine or fampridine is a Commodity code covering a specific pharmaceutical product used primarily to improve mobility in patients with multiple sclerosis. State and local procurement activity under this code centers on pharmaceutical purchasing by health departments, corrections systems, and public health agencies that stock or dispense this medication as part of their formulary management or inmate care programs. The code reflects direct procurement of the active pharmaceutical ingredient or finished dosage forms, typically through established state Medicaid purchasing channels, pharmacy benefit manager contracts, or public health agency formularies rather than through custom compounding or clinical trial supply arrangements.

The source provides no recent state and local contract opportunities tagged to this code. Without posted solicitation data, the geographic distribution and issuing-body concentration cannot be characterized from current procurement activity.